Literature DB >> 26129893

Brain calcification process and phenotypes according to age and sex: Lessons from SLC20A2, PDGFB, and PDGFRB mutation carriers.

Gaël Nicolas1,2,3, Camille Charbonnier2,3, Roberta Rodrigues de Lemos4, Anne-Claire Richard2, Olivier Guillin3,5, David Wallon2,3,6, Andrea Legati7, Daniel Geschwind7,8, Giovanni Coppola7,8, Thierry Frebourg1,3, Dominique Campion2,3,9, João Ricardo Mendes de Oliveira4,10, Didier Hannequin1,2,3,6.   

Abstract

Primary Familial Brain Calcification (PFBC) is a dominantly inherited cerebral microvascular calcifying disorder with diverse neuropsychiatric expression. Three causative genes have been identified: SLC20A2, PDGFRB and, recently, PDGFB, whose associated phenotype has not yet been extensively studied. We included in the largest published case series of genetically confirmed PFBC, 19 PDGFB (including three new mutations), 24 SLC20A2 (including 4 new mutations), and 14 PDGFRB mutation carriers, from two countries (France and Brazil). We studied clinical features and applied our visual rating scale on all 49 available CT scans. Among the symptomatic mutation carriers (33/57, 58%), the three most frequently observed categories of clinical features were psychiatric signs (72.7%, 76.5%, and 80% for PDGFB, SLC20A2, and PDGFRB, respectively), movement disorders (45.5%, 76.5%, and 40%), and cognitive impairment (54.6%, 64.7%, and 40%). The median age of clinical onset was 31 years, 25% had an early onset (before 18) and 25% a later onset (after 53). Patients with an early clinical onset exhibited mostly isolated psychiatric or cognitive signs, while patients with a later onset exhibited mostly movement disorders, especially in association with other clinical features. CT scans rating allowed identifying four patterns of calcification. The total calcification score was best predicted by the combined effects of gene (SLC20A2 > PDGFB > PDGFRB mutations), sex (male), and (increasing) age, defining three risk classes, which correlated with the four patterns of calcification. These calcification patterns could reflect the natural history of the calcifying process, with distinct risk classes characterized by different age at onset or rate of progression.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fahr disease; PDGFB; PDGFRB; SLC20A2; idiopathic basal ganglia calcification; primary familial brain calcification

Mesh:

Substances:

Year:  2015        PMID: 26129893     DOI: 10.1002/ajmg.b.32336

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  27 in total

1.  Primary brain calcification: an international study reporting novel variants and associated phenotypes.

Authors:  Eliana Marisa Ramos; Miryam Carecchio; Roberta Lemos; Joana Ferreira; Andrea Legati; Renee Louise Sears; Sandy Chan Hsu; Celeste Panteghini; Luca Magistrelli; Ettore Salsano; Silvia Esposito; Franco Taroni; Anne-Claire Richard; Christine Tranchant; Mathieu Anheim; Xavier Ayrignac; Cyril Goizet; Marie Vidailhet; David Maltete; David Wallon; Thierry Frebourg; Lylyan Pimentel; Daniel H Geschwind; Olivier Vanakker; Douglas Galasko; Brent L Fogel; A Micheil Innes; Alison Ross; William B Dobyns; Diana Alcantara; Mark O'Driscoll; Didier Hannequin; Dominique Campion; João R Oliveira; Barbara Garavaglia; Giovanni Coppola; Gaël Nicolas
Journal:  Eur J Hum Genet       Date:  2018-06-28       Impact factor: 4.246

2.  Identification of partial SLC20A2 deletions in primary brain calcification using whole-exome sequencing.

Authors:  Stéphanie David; Joana Ferreira; Olivier Quenez; Anne Rovelet-Lecrux; Anne-Claire Richard; Marc Vérin; Snejana Jurici; Isabelle Le Ber; Anne Boland; Jean-François Deleuze; Thierry Frebourg; João Ricardo Mendes de Oliveira; Didier Hannequin; Dominique Campion; Gaël Nicolas
Journal:  Eur J Hum Genet       Date:  2016-06-01       Impact factor: 4.246

Review 3.  Brain Calcification and Movement Disorders.

Authors:  Vladimir S Kostić; Igor N Petrović
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

4.  XPR1 mutations are a rare cause of primary familial brain calcification.

Authors:  Mathieu Anheim; Uriel López-Sánchez; Donatella Giovannini; Anne-Claire Richard; Jawida Touhami; Ludovic N'Guyen; Gabrielle Rudolf; Anne Thibault-Stoll; Thierry Frebourg; Didier Hannequin; Dominique Campion; Jean-Luc Battini; Marc Sitbon; Gaël Nicolas
Journal:  J Neurol       Date:  2016-05-26       Impact factor: 4.849

5.  Novel mutations of PDGFRB cause primary familial brain calcification in Chinese families.

Authors:  Chong Wang; Xiang-Ping Yao; Hai-Ting Chen; Jing-Hui Lai; Xin-Xin Guo; Hui-Zhen Su; En-Lin Dong; Qi-Jie Zhang; Ning Wang; Wan-Jin Chen
Journal:  J Hum Genet       Date:  2017-03-16       Impact factor: 3.172

6.  New Data from Pdfgb ret/ret Mutant Mice Might Lead to a Paradoxical Association Between Brain Calcification, Pericytes Recruitment and BBB Integrity.

Authors:  Denis A P Moura; Roberta R Lemos; João R M Oliveira
Journal:  J Mol Neurosci       Date:  2017-11-02       Impact factor: 3.444

Review 7.  Mechanisms of calcification in Fahr disease and exposure of potential therapeutic targets.

Authors:  Melissa E M Peters; Esther J M de Brouwer; Jonas W Bartstra; Willem P Th M Mali; Huiberdina L Koek; Annemieke J M Rozemuller; Annette F Baas; Pim A de Jong
Journal:  Neurol Clin Pract       Date:  2020-10

8.  Fahr's Syndrome Misdiagnosed As Delusional Disorder: A Case Report.

Authors:  Onur Hurşıtoğlu; Taha Can Tuman
Journal:  Noro Psikiyatr Ars       Date:  2020-05-05       Impact factor: 1.339

Review 9.  Mouse models of SLC4-linked disorders of HCO3--transporter dysfunction.

Authors:  Mark D Parker
Journal:  Am J Physiol Cell Physiol       Date:  2018-01-31       Impact factor: 4.249

10.  Interplay between primary familial brain calcification-associated SLC20A2 and XPR1 phosphate transporters requires inositol polyphosphates for control of cellular phosphate homeostasis.

Authors:  Uriel López-Sánchez; Sandrine Tury; Gaël Nicolas; Miranda S Wilson; Snejana Jurici; Xavier Ayrignac; Valérie Courgnaud; Adolfo Saiardi; Marc Sitbon; Jean-Luc Battini
Journal:  J Biol Chem       Date:  2020-05-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.